SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-106417
Filing Date
2017-03-31
Accepted
2017-03-31 15:39:32
Documents
1
Group Members
KAGOSHIMA DEVELOPMENT CO. LTD.MASAHARU TANAKA

Document Format Files

Seq Description Document Type Size
1 SC 13D AMENDMENT NO. 1 d369652dsc13da.htm SC 13D/A 54220
  Complete submission text file 0001193125-17-106417.txt   56051
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Subject) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89180 | Film No.: 17730115
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6-1-20, NANEI KAGOSHIMA CITY KAGOSHIMA M0 891-0122
Business Address 6-1-20, NANEI KAGOSHIMA CITY KAGOSHIMA M0 891-0122 81-99-260-3311
Kagoshima Shinsangyo Sousei Investment Limited Partnership (Filed by) CIK: 0001657769 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC 13D/A